PA Department of Health Trainings for Clinicians and Non-Clinicians: Caring for People with Xylazine-Associated Wounds

Oct. 2024Education/Webinars

The Pennsylvania Department of Health (PA DOH) and Philadelphia Department of Public Health (PDPH), in collaboration with the Center for Forensic Science Research & Education (CSFRE), are providing virtual trainings to clinicians and non-clinicians on best practices for caring for individuals with xylazine-associated wounds. These trainings are offered at no-cost to attendees.

These trainings will be offered in two separate two-hour sessions for individuals and organizations who work in Pennsylvania. The first live webinar on Oct. 23 will be for nonclinicians and the second live webinar on Nov. 6 will be for clinicians.

Click here to register for the CLINICAL training.

*This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and Center for Forensic Science, Research and Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Click here to register for the NONCLINICAL training.

*Certified Recovery Specialists (CRS) who complete this training may utilize credits to meet certification/re-certification training requirements. A training certificate will be provided to all attendees who complete the post-training assessment.

Please note: To register for a training you must create an account in CFSRE’s training platform.

Provider is responsible for verifying CME eligibility.


Recent Announcements

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Nov. 2025Important Notices

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Nov. 2025Education/Webinars